TerThera b.v.

Booth: B07

Silver Sponsor

Netherlands

TerThera b.v. is a Netherlands-based company dedicated to the production of innovative medical radionuclides, with a core focus on Terbium-161 (Tb-161). Founded by experts with decades of experience in nuclear medicine, TerThera aims to meet the rising global demand for radiotherapeutics in oncology.

Tb-161 is a promising lanthanide for radioligand therapy, offering enhanced anti-tumor properties thanks to its high emission of Auger and conversion electrons. TerThera is preparing GMP-grade production of this carrier-free (NCA) isotope to support advanced cancer treatments worldwide.